The utility of serologic tests as biomarkers for Helicobacter pylori-associated precancerous lesions and gastric cancer varies between Latin American countries
- 27 November 2012
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cancer Causes & Control
- Vol. 24 (2), 241-248
- https://doi.org/10.1007/s10552-012-0106-8
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Serum Helicobacter pylori CagA antibody as a biomarker for gastric cancer in east-Asian countriesFuture Microbiology, 2010
- Anthropological and clinical implications for the structural diversity of the Helicobacter pylori CagA oncoproteinCancer Science, 2010
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- The global burden of cancer: priorities for preventionCarcinogenesis: Integrative Cancer Research, 2009
- Recent patterns in gastric cancer: A global overviewInternational Journal of Cancer, 2009
- Gastric cancerBritish Medical Bulletin, 2008
- Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouseProceedings of the National Academy of Sciences of the United States of America, 2008
- CagA and VacAHelicobacter PyloriAntibodies in Gastric CancerCanadian Journal of Gastroenterology, 2008
- Helicobacter pylori cag pathogenicity island genes: clinical relevance for peptic ulcer disease development in BrazilJournal of Medical Microbiology, 2007
- Is Helicobacter pylori Infection a Necessary Condition for Noncardia Gastric Cancer?American Journal of Epidemiology, 2004